Cited by 12Traumatic Brain Injury ResearchAlzheimer's disease research and treatmentsMedical Imaging Techniques and Applications

Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward

Filippi, Luca, Schillaci, Orazio, Palumbo, Barbara·2022·Expert Review of Molecular Diagnostics

Abstract

Introduction Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative syndrome, caused by single or repeated traumatic brain injuries. Since a few years ago, post mortem examination represented the only effective method to diagnose CTE through the detection of its peculiar neuropathological features (i.e. tau protein aggregates) at a macroscopic and microscopic level. Several efforts have been made to develop radiopharmaceuticals characterized by high affinity for tau aggregates, suitable for imaging through positron emission computed tomography (Tau-PET).Areas covered The various radiopharmaceuticals utilized for the molecular imaging of CTE through Tau-PET are covered, with specific reference to their applications in clinical practice. Furthermore, PET probes binding to the translocator protein (TSPO), a marker of brain injury and repair, are reviewed as potential tools for the imaging of neuroinflammatory cascade associated with CTE.Expert opinion Molecular neuroimaging of CTE with Tau-PET is an intriguing, although still not completely explored, tool for the in vivo detection and monitoring of neuropathological hallmarks associated with CTE. Furthermore, some novel tracers, such as TSPO-ligands, hold the promise to get an insight into the complex physiopathological mechanisms leading from brain injury to symptomatic CTE.

Integrity signals

Registry

Crossref · 10.1080/14737159.2022.2035723

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Neurological applications of radiopharmaceutical theranostics encompass diagnosis and monitoring of neurodegenerative disorders, providing insights into neural function and degeneration patterns.

    “Neurological applications encompass the diagnosis and monitoring of neurodegenerative disorders, with radiopharmaceuticals providing insights into neural function and degeneration patterns [50].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Filippi, L., Schillaci, O., & Palumbo, B.
Affiliations
  • Ospedale Santa Maria Goretti (IT)
  • University of Rome Tor Vergata (IT)
  • University of Perugia (IT)
Corresponding author
Filippi, Luca
Venue
Expert Review of Molecular Diagnostics
Published
2022-02
Volume
22
Issue
2
Pages
149-156
ISSN
  • 1473-7159 (ISSN-L)
  • 1744-8352
OpenAlex
W4210580998
Cited by
12
References
47
Citations by year
2025: 1 · 2024: 4 · 2023: 6 · 2022: 1
FWCI
2.17
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Review of Molecular Diagnostics (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
chronic traumatic encephalopathy, tau PET, translocator protein (TSPO), TSPO ligands, neuroinflammation, molecular neuroimaging, traumatic brain injury, neurodegeneration, in vivo diagnosis
MeSH terms
Chronic Traumatic Encephalopathy, Positron Emission Tomography Computed Tomography, Humans, Nuclear Medicine, Receptors, GABA, Positron-Emission Tomography, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review